Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population

Journal of Lipid Research

Volumn 50, Issue 3, 2009, Pages 514-520

  Tai, E Shyong ^a   Sim, Xue Ling ^b   Ong, Twee Hee ^d   Wong, Tien Yin ^c,e   Saw, Seang Mei ^c   Aung, Tin ^c   Kathiresan, Sekar ^f   Orho Melander, Marju ^g   Ordovas, Jose M ^h   Tan, Jonathan T ^b   Seielstad, Mark ^d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g LUND UNIVERSITY   (Sweden)

^h TUFTS UNIVERSITY   (United States)

Author keywords

Coronary heart disease; Ethnic group; Genetics

Indexed keywords

CHOLESTEROL; CHROMOSOME PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN CILP2; PROTEIN GALNT2; PROTEIN PBX4; TRIBBLES 1; UNCLASSIFIED DRUG; LIPID; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRIB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASIAN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHROMOSOME 1; CHROMOSOME 19; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; HUMAN; INHERITANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ALLELE; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETICS; MALAYSIA; MIDDLE AGED; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENE FREQUENCY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPIDS; MALAYSIA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; SINGAPORE;

EID: 64349100189     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800456-JLR200     Document Type: Article

References (28)

1. Brown, B. G., K. H. Stukovsky, and X. Q. Zhao. 2006. Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr. Opin. Lipidol. 17: 631-636.
2. Heller, D. A., U. de Faire, N. L. Pedersen, G. Dahlen, and G. E. McClearn. 1993. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328: 1150-1156.
3. Kathiresan, S., O. Melander, C. Guiducci, A. Surti, N. P. Burtt, M. J. Rieder, G. M. Cooper, C. Roos, B. F. Voight, A. S. Havulinna, et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197.
4. Kooner, J. S., J. C. Chambers, C. A. Aguilar-Salinas, D. A. Hinds, C. L. Hyde, G. R. Warnes, F. J. Gomez Perez, K. A. Frazer, P. Elliott, J. Scott, et al. 2008. Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat. Genet. 40: 149-151.
5. Sandhu, M. S., D. M. Waterworth, S. L. Debenham, E. Wheeler, K. Papadakis, J. H. Zhao, K. Song, X. Yuan, T. Johnson, S. Ashford, et al. 2008. LDL-cholesterol concentrations: a genome-wide association study. Lancet. 371: 483-491.
6. Willer, C. J., S. Sanna, A. U. Jackson, A. Scuteri, L. L. Bonnycastle, R. Clarke, S. C. Heath, N. J. Timpson, S. S. Najjar, H. M. Stringham, et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40: 161-169.
7. Yusuf, S., S. Reddy, S. Ounpuu, and S. Anand. 2001. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 104: 2746-2753.
8. Yusuf, S., S. Reddy, S. Ounpuu, and S. Anand. 2001. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 104: 2855-2864.
9. Foong, A. W., S. M. Saw, J. L. Loo, S. Shen, S. C. Loon, M. Rosman, T. Aung, D. T. Tan, E. S. Tai, and T. Y. Wong. 2007. Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay eye study (SiMES). Ophthalmic Epidemiol. 14: 25-35.
10. Shankar, A., C. Leng, K. S. Chia, D. Koh, E. S. Tai, S. M. Saw, S. C. Lim, and T. Y. Wong. 2007. Association between body mass index and chronic kidney disease in men and women: population-based study of Malay adults in Singapore. Nephrol. Dial. Transplant. 23: 1910-1918.
11. Su, D. H., T. Y. Wong, W. L. Wong, S. M. Saw, D. T. Tan, S. Y. Shen, S. C. Loon, P. J. Foster, and T. Aung. 2007. Diabetes, hyperglycemia, and central corneal thickness: the Singapore Malay Eye Study. Ophthalmology. 115: 964-968.
12. Leow, B., editor. 2001. Singapore Census of Population 2000: Statistical Release 1 - Demographic Characteristics. Department of Statistics, Singapore.
13. Leow, B., editor. 2001. Singapore Census of Population 2000: Statistical Release 5 - Households and Housing. Department of Statistics, Singapore.
14. Levey, A. S., J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth. 1999. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 130: 461-470.
15. Chanock, S. J., T. Manolio, M. Boehnke, E. Boerwinkle, D. J. Hunter, G. Thomas, J. N. Hirschhorn, G. Abecasis, D. Altshuler, J. E. Bailey-Wilson, et al. 2007. Replicating genotype-phenotype associations. Nature. 447: 655-660.
16. Cohen, J. C., E. Boerwinkle, T. H. Mosley, Jr., and H. H. Hobbs. 2006. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 354: 1264-1272.
17. Brown, M. S., and J. L. Goldstein. 2006. Biomedicine. Lowering LDL-not only how low, but how long? Science. 311: 1721-1723.
18. Hegedus, Z., A. Czibula, and E. Kiss-Toth. 2006. Tribbles: novel regulators of cell function; evolutionary aspects. Cell Mol Life Sci. 63: 1632-1641.
19. Sung, H. Y., H. Guan, A. Czibula, A. R. King, K. Eder, E. Heath, S. K. Suvarna, S. K. Dower, A. G. Wilson, S. E. Francis, D. C. Crossman, and E. Kiss-Toth. 2007. Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem. 282: 18379-18387.
20. Rauch, U., K. Feng, and X. H. Zhou. 2001. Neurocan: a brain chondroitin sulfate proteoglycan. Cell. Mol. Life Sci. 58: 1842-1856.
21. Lin, C. Y., Z. H. Huang, and T. Mazzone. 2001. Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE. J. Lipid Res. 42: 1125-1133.
22. Lucas, M., and T. Mazzone. 1996. Cell surface proteoglycans modulate net synthesis and secretion of macrophage apolipoprotein E. J. Biol. Chem. 271: 13454-13460.
23. Lasky-Su, J., H. N. Lyon, V. Emilsson, I. M. Heid, C. Molony, B. A. Raby, R. Lazarus, B. Klanderman, M. E. Soto-Quiros, L. Avila, et al. 2008. On the replication of genetic associations: timing can be everything! Am. J. Hum. Genet. 82: 849-858.
24. Wilder, L. B., P. S. Bachorik, C. A. Finney, T. F. Moy, and D. M. Becker. 1995. The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol. Am. J. Med. 99: 374-377.
25. Craig, S. R., R. V. Amin, D. W. Russell, and N. F. Paradise. 2000. Blood cholesterol screening influence of fasting state on cholesterol results and management decisions. J. Gen. Intern. Med. 15: 395-399.
26. de Ferranti, S., D. Shapiro, R. Markowitz, E. Neufeld, N. Rifai, and H. Bernstein. 2007. Nonfasting low-density lipoprotein testing: utility for cholesterol screening in pediatric primary care. Clin. Pediatr. (Phila.). 46: 441-445.
27. Weiss, R., M. Harder, and J. Rowe. 2003. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3- methylglutaryl-coenzyme A reductase inhibitors. Clin. Ther. 25: 1490-1497.
28. Yu, H. H., G. S. Ginsburg, N. Harris, and N. Rifai. 1997. Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am. J. Cardiol. 80: 1295-1299